The size of the Smart Pills Technologies Market in APAC was worth USD 677 Million in 2023 and is projected to reach USD 1588 Million by 2028, growing at a CAGR of 18.4% from 2023 to 2028.
The growing patient population of chronic diseases such as cancer, diabetes, obesity and gastric ulcer among the population of the APAC region majorly drives the growth of the APAC smart pill technologies market. Factors such as lifestyle changes, low-fiber diets and sedentary lifestyles contribute to the occurrence of gastrointestinal disorders. Smart pills play a crucial role in detecting abnormalities in the gastrointestinal tract, monitoring food passage, and identifying infections. These innovative pills are equipped with ingestible sensors that record various physiological measures within the body. Patients can easily consume smart pills as they would with conventional pills. As the smart pill travels through the digestive tract, it collects valuable health data, captures images, and facilitates drug delivery.
The growing geriatric population and rising awareness about smart pill technologies in the Asia-Pacific region further propel the regional market growth. The Asia Pacific region had approximately 630 million people aged 60 and above in 2020, highlighting the significant market potential. The older population is increasingly adopting non-invasive surgical procedures, which has contributed to the rise in market demand for smart pill technologies. Smart pills offer a non-invasive approach to diagnose diseases and detect issues within the patient's body, eliminating the need for cuts or surgeries. Additionally, these advanced pills assist in monitoring medication adherence, ensuring patients take their prescribed medications as directed.
The growing number of advancements in smart pill technology within the healthcare sector in the APAC region promotes the regional market growth. Researchers are dedicated to developing smart pills that incorporate advanced technologies, including IoT-based technology. These innovations aim to enhance the treatment process and provide healthcare professionals with a comprehensive view of patients' conditions for accurate diagnosis. Manufacturers are focused on tailoring smart pills based on specific factors, such as symptoms experienced by patients and their age groups. This targeted approach ensures effective and personalized healthcare solutions. The rising investments in research and development, strong support from pharmaceutical companies and the approval of novel medications to address various healthcare challenges favors the APAC smart pills technologies market.
The high cost associated with smart pill technology treatments is one of the major factors hampering the APAC market growth. The expensive sensors and cameras used in smart pills contribute to the overall high cost, making it challenging for many healthcare facilities, particularly those with limited resources, to afford such technologies. The lack of skilled professionals, inadequate awareness about smart pill technology among the rural population and the absence of favorable reimbursement policies further impede market growth.
This research report on the Asia Pacific Smart Pills Technologies Market has been segmented and sub-segmented into the following categories.
The Asia Pacific region was the third largest regional market worldwide in 2022 and is expected to showcase the highest CAGR during the forecast period. The widespread adoption of advanced technologies in the medical sector and the substantial healthcare expenditure by the population drive the APAC market growth. Key players and healthcare organizations have conducted various training programs to equip healthcare providers with the necessary skills for improved treatment outcomes. Extensive awareness programs and targeted advertisements have successfully increased awareness about smart pill technologies among the population, thereby contributing to market growth.
China is a promising regional market for smart pill technologies in the Asia-Pacific region and is expected to do well during the forecast period owing to the development of novel drugs that enhance patient healthcare facilities. China benefits from a growing number of pharmaceutical companies and the presence of key players, which drive market expansion. The rising demand for advanced drug delivery systems further fuels market growth in China. India and Japan are expected to register a healthy growth rate during the forecast period due to their expanding medical device manufacturing facilities and the establishment of numerous clinical trial centers. These countries experience a surge in early diagnosis rates and a growing patient population, driving the market forward
KEY MARKET PLAYERS
Noteworthy Companies dominating the Asia Pacific Smart Pills Technologies Market Profiled in the Report are CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, Bio-Images Research Limited, Novartis, Philips Healthcare, Siemens Healthcare, Stryker Corporation, GE Healthcare, Boston Scientific Corporation, Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc, Given Imaging Ltd, Smartpill, Inc., Medtronic, Inc., Pentax Medical Company, IntroMedic Inc.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]